K A Schoedel

Summary

Publications

  1. ncbi Assessing abuse liability during drug development: changing standards and expectations
    K A Schoedel
    Clinical Pharmacology Group, DecisionLine Clinical Research Corporation, Toronto, Ontario, Canada
    Clin Pharmacol Ther 83:622-6. 2008
  2. ncbi Subjective and objective effects of the novel triple reuptake inhibitor tesofensine in recreational stimulant users
    K A Schoedel
    Kendle Early Stage Toronto, Ontario, Canada
    Clin Pharmacol Ther 88:69-78. 2010
  3. ncbi Induction of CYP2B1/2 and nicotine metabolism by ethanol in rat liver but not rat brain
    K A Schoedel
    Department of Pharmacology, University of Toronto, 1 King's College Circle, M5S 1A8, Toronto, Ontario, Canada
    Biochem Pharmacol 62:1025-36. 2001
  4. ncbi Evaluation of the abuse potential of lorcaserin, a serotonin 2C (5-HT2C) receptor agonist, in recreational polydrug users
    M J Shram
    Kendle Early Stage, Toronto, Ontario, Canada
    Clin Pharmacol Ther 89:683-92. 2011

Detail Information

Publications4

  1. ncbi Assessing abuse liability during drug development: changing standards and expectations
    K A Schoedel
    Clinical Pharmacology Group, DecisionLine Clinical Research Corporation, Toronto, Ontario, Canada
    Clin Pharmacol Ther 83:622-6. 2008
    ....
  2. ncbi Subjective and objective effects of the novel triple reuptake inhibitor tesofensine in recreational stimulant users
    K A Schoedel
    Kendle Early Stage Toronto, Ontario, Canada
    Clin Pharmacol Ther 88:69-78. 2010
    ..These results demonstrate that the abuse potential for tesofensine is no greater than that of bupropion or atomoxetine, and tesofensine is therefore unlikely to be recreationally abused...
  3. ncbi Induction of CYP2B1/2 and nicotine metabolism by ethanol in rat liver but not rat brain
    K A Schoedel
    Department of Pharmacology, University of Toronto, 1 King's College Circle, M5S 1A8, Toronto, Ontario, Canada
    Biochem Pharmacol 62:1025-36. 2001
    ....
  4. ncbi Evaluation of the abuse potential of lorcaserin, a serotonin 2C (5-HT2C) receptor agonist, in recreational polydrug users
    M J Shram
    Kendle Early Stage, Toronto, Ontario, Canada
    Clin Pharmacol Ther 89:683-92. 2011
    ..The findings suggest that, at supratherapeutic doses, lorcaserin is associated with distinct, primarily negative, subjective effects and has low abuse potential...